Evidence map›Paper›PMID 39801856›Full record

ArticleJournal of orthopaedic case reports2025

Rare Coexistence: Giant Cell Tumor Recurrence and Infection in the Proximal Tibia - A Case Report.

Mainak Roy, Harsha Vardhan Reddy, Suhas Aradhya Bhikshavarthimath, Samir Chandrakant Dwidmuthe, Vivek Tiwari

Abstract readCase Reports
In one paragraph

Article in Journal of orthopaedic case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mainak RoyDepartment of Orthopedics, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
Harsha Vardhan ReddyDepartment of Orthopedics, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
Suhas Aradhya BhikshavarthimathDepartment of Orthopedics, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
Samir Chandrakant DwidmutheDepartment of Orthopedics, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
Vivek TiwariDepartment of Orthopedics, Apollo sage hospitals, Bhopal, Madhya Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Giant cell tumor of bone (GCTB) ranks among the most prevalent locally aggressive tumor lesions, displaying a diverse range of biological behaviors. Recurrence of GCTB is well-documented, often attributed to microscopic tumour remnants remaining after intralesional curettage, with increased concern when infection occurs postoperatively. Studies suggest the limited effectiveness of adjuvants in preventing giant cell tumour recurrence, emphasizing the necessity of complete removal of malignant cells. We describe our experience with a rare presentation of recurrence together with infection in an operated case of GCTB right proximal tibia with curettage with cementing and plate stabilization. Case Report: A 28 year-old female who was operated case of GCTB right proximal tibia with curettage with cementing and plate stabilization in 2020 presented to our outpatient department with complaints pain in right leg while walking for 3 months in October 2021. Plain radiography of the right knee suggestive of lytic lesion over medial aspect of the right tibia around cement with plate in situ and magnetic resonance imaging right knee suggestive of recurrence of the tumor with no breach in joint line and no involvement of neurovascular structures. The patient was planned for implant removal with extended curettage and plate stabilization and cementing with antibiotics (vancomycin and gentamycin) after sending tissues for culture sensitivity and histopathology. Intraoperative cultures showed growth of methicillin-sensitive staphylococcus aureus which was sensitive to cefoxitin, gentamicin, cotrimoxazole, and doxycycline following which pt received 2 weeks of intravenous antibiotics and 4 weeks of oral antibiotics as per culture sensitivity with no post-operative wound complications and had satisfactory functional outcome. The patient was followed at regular intervals till 2-year follow-up did not show any signs of recurrence and infection. Conclusion: The manifestation of GCTB recurrence alongside infection is exceedingly rare with limited literature evidence. Our case illustrates a method to address both issues concurrently during a single procedure, utilizing antibiotic bone cement to tackle infection and extended curettage for thorough removal of neoplastic cells from the surrounding bone.

Indexed as

Giant cell tumorinfectionrecurrence

Identifiers

PMID39801856
PMCPMC11723728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.